Oncology Nutrition Market Experiences Growth with Rise in Personalized and Immuno-nutrition Trends
22 janv. 2024 21h28 HE
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Nutrition Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The recent comprehensive analysis within...
Oncology Devices Market Set for Robust Expansion, with AI Innovations and Advancements in Radiation Therapy Techniques
22 janv. 2024 21h18 HE
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global oncology devices market is...
3D Cell Cultures Market to Cross US$ 3.1 Billion on by 2033 Driven by Increased Biological Relevance and Rising Incidence of Chronic Diseases | Persistence Market Research
18 janv. 2024 04h30 HE
|
Persistence Market Research
New York, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Market Size & Overview: In 2022, the 3D cell culture market reached a global revenue of US$1.2 billion, and projections indicate a Compound Annual...
FRED’S TEAM SETS HISTORIC $8 MILLION FUNDRAISING RECORD FOR CANCER RESEARCH
17 janv. 2024 09h00 HE
|
Memorial Sloan Kettering Cancer Center
New York, NY, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Fred’s Team, the official running program of Memorial Sloan Kettering Cancer Center (MSK), set a new single-season fundraising record in 2023 by...
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
08 déc. 2023 09h15 HE
|
Novartis Pharma AG
With 5.6 months of additional follow-up and 78.3% of patients having completed Kisqali® (ribociclib) investigational treatment, the updated analysis shows sustained iDFS benefit and stability in...
ELISpot and FluoroSpot Assay Market is Expected to Reach $421 million | MarketsandMarkets.
04 déc. 2023 07h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Dec. 04, 2023 (GLOBE NEWSWIRE) -- ELISpot and FluoroSpot Assay market in terms of revenue was estimated to be worth $292 million in 2023 and is poised to reach $421 million by 2028, growing...
Cell Culture Consumables Market revenue to reach USD 400 Billion by 2036, says Research Nester
21 nov. 2023 07h30 HE
|
Research Nester
New York, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global cell culture consumables market size is projected to grow at a CAGR of over ~23% from 2024 to 2036. The market is expected to garner a revenue...
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
03 nov. 2023 06h00 HE
|
Turnstone Biologics Corp.
Posters showcase Turnstone’s novel Selected TIL programs which are designed to selectively expand the most potent tumor-reactive T cells for solid tumors.
Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results
01 nov. 2023 16h10 HE
|
Prelude Therapeutics, Inc.
Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
01 nov. 2023 16h05 HE
|
Prelude Therapeutics, Inc.; AbCellera
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology